Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort. - Wikidata - awgldk - TriplyDB

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

http://www.wikidata.org/entity/Q35119311

about

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada Suicide mortality among people accessing highly active antiretroviral therapy for HIV/AIDS in British Columbia: a retrospective analysis Prevalence and predictors of facing a legal obligation to disclose HIV serostatus to sexual partners among people living with HIV who inject drugs in a Canadian setting:a cross-sectional analysis Awareness and understanding of HIV non-disclosure case law among people living with HIV who use illicit drugs in a Canadian setting.Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012 Is there a rural/urban gap in the quality of HIV care for treatment-naïve HIV-positive individuals initiating antiretroviral therapy in British Columbia?Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada.Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada.Novel HLA class I associations with HIV-1 control in a unique genetically admixed population.The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study.HLA-C downregulation by HIV-1 adapts to host HLA genotype

P2860

Q28610686-E6F5820E-120A-467A-AD23-CE4C7CD1AF64 Q36045908-7E8323A7-A578-463E-BF00-D726D2237E31 Q37066888-5BA17430-2B4F-4777-A5B4-B15F14A178AB Q38864466-B174182F-8E10-45D6-80C2-FFED87D6B3FB Q39697959-3B4B7A42-C7D8-4BC9-97B8-49798D9572B6 Q40466607-C9EC8AE7-CCE1-44E1-B7EC-25E50D472741 Q47547280-41B83F6C-0519-48C2-9E37-7DB4C0DA2D29 Q47582376-96396B53-EFAF-48A8-BFDD-933B02A57FB4 Q54233740-9A11B206-6173-45F6-B88D-5E4B6D602FB6 Q55339576-21393368-0304-4065-8837-E775E9330FD4 Q56909688-FF635190-81EC-4389-B79A-791C6F028D64

P2860

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

http://www.wikidata.org/entity/Q35119311

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

@ast

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

@en

type

label

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

@ast

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

@en

prefLabel

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

@ast

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

@en

P1433

Q35119311-EC36DC2C-B554-4AED-9562-43B97E5F2B1C

P1476

Q35119311-3B1470AB-1E33-4616-8836-F983AAFF1181

P2093

Q35119311-020958F8-6B89-48A2-88C5-509AA5CDFB6B

Q35119311-29F418EF-CF53-4044-AE33-8252D2C9B3EC

Q35119311-39210C0C-C981-44DC-ADED-50CE4E2C01EF

Q35119311-56D7BA1E-F0AB-4949-8911-46251849829E

Q35119311-73D67DCD-B9F7-4890-9E55-386677F2F5CE

Q35119311-74E33D50-6A98-4D90-A45F-EFF3EC607CF2

Q35119311-987AB384-3BE2-4E4B-A626-563EA9063D62

Q35119311-B4C7081C-D8CA-4FCA-9638-E06ED6F4F766

Q35119311-BFDD3073-56CA-4C26-9ECF-3492A71AA697

Q35119311-CB449FCB-F801-440F-BC6B-E2A026BBD264

P2860

Q35119311-00B4967D-E33C-461F-AA5D-6C017DEE2D97

Q35119311-039B58C1-3433-44AA-BB56-3CF1FD316264

Q35119311-07CB0BF5-20EE-4108-AAFA-A84B0FD98E1D

Q35119311-152D6CF1-C9DB-4353-9F46-368D14E40C2E

Q35119311-17575D22-601A-4457-8DDE-C605B9B7E7C8

Q35119311-19DA9473-3C87-4781-B258-56604129AF45

Q35119311-20226217-6B3D-4315-9745-F2C86565B641

Q35119311-21EB1566-6379-4D99-A6F8-D2E9A76B553D

Q35119311-26D8E898-8B9F-4734-A8F6-2228E0AE8C5D

Q35119311-3E489C60-4EC4-466D-BC2C-EF714F789DA5

P304

Q35119311-37D2A3C6-DE4C-4DD3-8C7D-E255528DB1C0

P31

Q35119311-08C789C4-63A1-45E5-9BC0-C9EE942F605E

P356

Q35119311-49DE8EF2-5E59-4B95-8CB9-2275328B7271

P433

Q35119311-475069E5-1250-4B51-A73B-2D4A34DB9788

P478

Q35119311-E6110AB8-DF34-4AE9-A6B7-0C639681429C

P50

Q35119311-0021D05C-FF6C-4544-91D4-351E5DEC70A4

Q35119311-4B009AA7-7069-437C-8244-2733D6FEA785

Q35119311-A56AD0D3-EA0B-4590-947B-451E0694B52B

P577

Q35119311-1BF57876-1B9C-4836-B03E-7875892D5418

P5875

Q35119311-BF04BCF4-253D-4843-9FB8-7A8240B417E3

P698

Q35119311-9BA0A085-4147-4BE3-BA65-79E78CBE3F8D

P932

Q35119311-7E9B322F-DD87-43A6-8490-D2F2E07560D0

P356

P1433

International Journal of Epidemiology

P1476

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

@en

P2093

Angela Cescon

http://www.w3.org/2001/XMLSchema#string

Benita Yip

http://www.w3.org/2001/XMLSchema#string

Bohdan Nosyk

http://www.w3.org/2001/XMLSchema#string

David Moore

http://www.w3.org/2001/XMLSchema#string

Hasina Samji

http://www.w3.org/2001/XMLSchema#string

Kate Shannon

http://www.w3.org/2001/XMLSchema#string

Katherine J Lepik

http://www.w3.org/2001/XMLSchema#string

P Richard Harrigan

http://www.w3.org/2001/XMLSchema#string

Sophie Patterson

http://www.w3.org/2001/XMLSchema#string

Viviane D Lima

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens

Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008

Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada

Development and validation of a composite programmatic assessment tool for HIV therapy

Reconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence Data

HIV-1 disease progression during highly active antiretroviral therapy: an application using population-level data in British Columbia: 1996-2011.

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection.

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

P304

58-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/IJE/DYU046

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260876540

http://www.w3.org/2001/XMLSchema#string

P698

24639444

http://www.w3.org/2001/XMLSchema#string

P932

4339756

http://www.w3.org/2001/XMLSchema#string